Hiv/ Aids:

Abrams D.I., Hilton J.F., Leiser R.J., Shade S.B., Elbeik T.A., Aweeka F.T., Benowitz N.L., Bredt B.M., Kosel B., Aberg J.A., Deeks S.G., Mitchell T.F., Mulligan K., Bacchetti P., McCune J.M., Schambelan M. (2003). Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Annals of Internal Medicine;139(4):258-266.

Cannabis & THC/ oraal & inhalatie

Beal J.E., Olson R., Lefkowitz L., Laubenstein L., Bellman P., Yangco B., Morales J.O., Murphy R., Powderly W., Plasse T.F., Mosdell K.W., Shepard K.V. (1997). Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. Journal of Pain and Symptom Management;14(1):7-14.
THC/ oraal

Timpone J.G., Wright D.J., Li N., Egorin M.J., Enama M.E., Mayers J., Galetto G. (1997). The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. AIDS Research and Human Retroviruses;13(4):305-315.
THC/ oraal

Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., Lefkowitz L., Plasse T.F., Shepard K.V. (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain and Symptom Management;10(2):89-97.
THC/ oraal

Struwe M., Kaempfer S.H., Geiger C.J., Pavia A.T., Plasse T.F., Shepard K.V., Ries K., Evans T.G. (1993). Effect of dronabinol on nutritional status in HIV infection. Annals of Pharmacotherapy. Jul-Aug;27(7-8):827-31.
THC/ oraal

Gorter R., Seefried M., Volberding P. (1992). Dronabinol effects on weight in patients with HIV infection. AIDS;6(1):127.
THC/ oraal

Plasse T.F., Gorter R.W., Krasnow S.H., Lane M., Shepard K.V., Wadleigh R.G. (1991). Recent clinical experience with dronabinol. Pharmacology, Biochemistry and Behavior. Nov;40(3):695-700.
THC/ oraal